The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

AliveCor announced that CMS included its AI-powered ECG system in a final rule that sets a Medicare payment rate for the ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

handheld 12-lead ECG system with a unique single-cable design—performs comparably to a standard hospital-grade ECG for detecting common morphological cardiac abnormalities, including heart ...

including heart attack. Kardia 12L performed comparably to the standard 12-lead ECG in detecting major morphology-related abnormalities. "AliveCor's Kardia 12L ECG System was born from our vision ...

handheld 12-lead ECG system with a unique single-cable design—performs comparably to a standard hospital-grade ECG for detecting common morphological cardiac abnormalities, including heart attack. The ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

About Kardia 12L ECG and KAI 12L AI Technology Kardia 12L ECG System combines the power of KAI 12L's AI technology and the ...